MARKET

CDTX

Cidara Theraptcs
CDTX
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-8.2771
1900.26
15.38
6,960,047,951.98
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
Benzinga · 01/09 06:52
*News On Cidara Therapeutics Inc. (CDTX) Now Under MRK
Dow Jones · 01/07 22:08
Cidara Therapeutics Completes Acquisition and Becomes Private Company
TipRanks · 01/07 14:31
Merck completes cash tender offer for Cidara Therapeutics
Seeking Alpha · 01/07 12:28
Merck Completes Cash Tender Offer At Purchase Price Of $221.50 Per Share Of Common Stock Of Cidara Therapeutics
Benzinga · 01/07 11:55
*Merck: Nearly 86% of Cidara Shares Validly Tendered >MRK CDTX
Dow Jones · 01/07 11:46
Merck Completes Acquisition of Cidara Therapeutics
Reuters · 01/07 11:45
NASDAQ TRADE HALT <CDTX.O> TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Reuters · 01/07 00:50
More

Webull offers Cidara Theraptcs stock information, including NASDAQ: CDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTX stock methods without spending real money on the virtual paper trading platform.